Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HERCEPTIN for Adjuvant therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where HERCEPTIN was used for Adjuvant therapy.

Most Reported Side Effects for HERCEPTIN

Side Effect Reports % Deaths Hosp.
Disease progression 119 14.4% 25 9
Death 96 11.6% 96 5
Diarrhoea 64 7.7% 6 29
Nausea 55 6.6% 6 26
Fatigue 51 6.2% 2 18
Dyspnoea 49 5.9% 1 20
Headache 36 4.4% 2 9
Pain 34 4.1% 1 8
Febrile neutropenia 33 4.0% 2 9
Pyrexia 30 3.6% 0 17
Rash 30 3.6% 0 12
Asthenia 29 3.5% 1 9
Vomiting 29 3.5% 2 14
Metastases to central nervous system 28 3.4% 6 8
Pain in extremity 27 3.3% 1 8

Other Indications for HERCEPTIN

Breast cancer (332) Product used for unknown indication (175) Breast cancer metastatic (169) Her-2 positive breast cancer (48) Gastric cancer (17) Invasive ductal breast carcinoma (13) Breast cancer female (11) Palliative care (7) Breast cancer recurrent (6) Metastatic neoplasm (6)

Other Drugs Used for Adjuvant therapy

BREXPIPRAZOLE (2,296) CYCLOPHOSPHAMIDE (236) FLUOROURACIL (218) EPIRUBICIN (206) ARIPIPRAZOLE (171) CAPECITABINE (120) ZOLEDRONIC ACID (89) OXALIPLATIN (75) DOCETAXEL (65) LETROZOLE (64)

Related Pages

HERCEPTIN Full Profile All Adjuvant therapy Drugs HERCEPTIN Demographics HERCEPTIN Timeline